Thomas B. Smith
EVP and Chief Medical Officer · COLLEGIUM PHARMACEUTICAL, INC
- 2025
- Feb 12, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas B. Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Scott Dreyer - $2.02M in COLL purchases and sales in the last 12 months
- John A. Fallon - $1.65M in COLL purchases and sales in the last 12 months
- Colleen Tupper - $1.22M in COLL purchases and sales in the last 12 months
- David Dieter - $716K in COLL purchases and sales in the last 12 months
- Garen G. Bohlin - $323K in COLL purchases and sales in the last 12 months
- Nancy Lurker - $162K in COLL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas B. Smith?
Thomas B. Smith is a corporate insider, tracked as EVP and Chief Medical Officer of COLLEGIUM PHARMACEUTICAL, INC (COLL). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thomas B. Smith last file a Form 4?
The most recent primary Form 4 on record is dated 12 February 2026, one of 2 filings going back to 2025.
Has Thomas B. Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($672K) across all tracked filings.
